Sotera Health Announces Executive and Board Changes
Ticker: SHC · Form: 8-K · Filed: Sep 6, 2024 · CIK: 1822479
| Field | Detail |
|---|---|
| Company | Sotera Health Co (SHC) |
| Form Type | 8-K |
| Filed Date | Sep 6, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01, $15.03 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-composition, executive-compensation
Related Tickers: SHC
TL;DR
Sotera Health shakes up leadership and board on Sept 4th.
AI Summary
Sotera Health Company announced on September 4, 2024, changes in its executive team and board of directors. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key executives. These changes are effective as of the reporting date.
Why It Matters
Changes in leadership and board composition can signal shifts in company strategy, governance, or future performance, impacting investor confidence and stock valuation.
Risk Assessment
Risk Level: medium — Executive and board changes can introduce uncertainty regarding future strategy and operational stability.
Key Players & Entities
- Sotera Health Company (company) — Registrant
- September 4, 2024 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- Broadview Heights, Ohio (location) — Principal Executive Address
FAQ
What specific roles have seen departures or appointments within Sotera Health's executive team?
The filing indicates the departure of certain officers and the appointment of new officers, but does not specify the exact roles in this section.
Who are the newly elected directors of Sotera Health?
The filing states that directors have been elected, but does not name the individuals in this section.
What is the effective date of these reported changes?
The earliest event reported is dated September 4, 2024.
Are there any changes to the compensatory arrangements for Sotera Health's officers?
Yes, the filing explicitly mentions updates to compensatory arrangements of certain officers.
What is the primary business address of Sotera Health?
The primary business address is 9100 South Hills Blvd, Suite 300, Broadview Heights, Ohio 44147.
Filing Stats: 777 words · 3 min read · ~3 pages · Grade level 11.2 · Accepted 2024-09-06 16:36:01
Key Financial Figures
- $0.01 — nge on which registered Common stock, $0.01 par value per share SHC The Nasdaq
- $15.03 — the Selling Stockholders, at a price of $15.03 per share, subject to and upon the term
Filing Documents
- d891564d8k.htm (8-K) — 28KB
- d891564dex11.htm (EX-1.1) — 265KB
- d891564dex51.htm (EX-5.1) — 14KB
- g891564g33r87.jpg (GRAPHIC) — 4KB
- g891564g54k23.jpg (GRAPHIC) — 4KB
- g891564g83e73.jpg (GRAPHIC) — 7KB
- g891564g93x66.jpg (GRAPHIC) — 5KB
- 0001193125-24-215204.txt ( ) — 524KB
- shc-20240904.xsd (EX-101.SCH) — 2KB
- shc-20240904_lab.xml (EX-101.LAB) — 18KB
- shc-20240904_pre.xml (EX-101.PRE) — 11KB
- d891564d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 1.1 Underwriting Agreement, dated September 4, 2024, among the Company, Citigroup Global Markets Inc., as underwriter, and the selling stockholders named in Schedule 2 thereto. 5.1 Opinion of Cleary Gottlieb Steen & Hamilton LLP. 23.1 Consent of Cleary Gottlieb Steen & Hamilton LLP (included as part of Exhibit 5.1). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sotera Health Company (Registrant) Date: September 6, 2024 By: /s/ Jonathan M. Lyons Jonathan M. Lyons Senior Vice President and Chief Financial Officer